DocMorris Competitors

DOCM Stock

5.68 0.02 0.35%

DocMorris AG competes with IVF Hartmann, Coltene Holding, Newron Pharmaceuticals, Santhera Pharmaceuticals, and Molecular Partners; as well as few others. The company operates under Consumer Staples Distribution & Retail sector and is part of Consumer Staples industry. Analyzing DocMorris competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of DocMorris to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out DocMorris Correlation with its peers.

DocMorris vs Evolva Holding Correlation

Very good diversification

The correlation between DocMorris AG and EVE is -0.34 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding DocMorris AG and EVE in the same portfolio, assuming nothing else is changed.

Moving together with DocMorris Stock

0.64	BANB	Bachem Holding AG	Pair Corr
0.78	UBSG	UBS Group AG Earnings Call Today	Pair Corr
0.66	WKBN	Banque Cantonale	Pair Corr

Return On Tangible Assets is likely to climb to -0.37 in 2026. Return On Capital Employed is likely to climb to -0.17 in 2026. At this time, DocMorris' Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to climb to about 17.1 M in 2026, whereas Non Current Assets Total are likely to drop slightly above 342.2 M in 2026.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
1.67	5.63	9.59

Details

Intrinsic

Valuation

Low	Real	High
0.81	4.77	8.73

Details

Naive

Forecast

Low	Next	High
1.54	5.50	9.46

Details

Earnings

Estimates (0)

Low	Projected EPS	High
-0.66	-0.58	-0.48

Details

DocMorris Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between DocMorris and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of DocMorris and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of DocMorris AG does not affect the price movement of the other competitor.

	VBSN	CLTN	NWRN	SANN	MOLN	ASCN	SHLTN	ADXN	EVE
VBSN		0.69	0.58	0.59	-0.09	0.77	0.46	-0.53	-0.38	VBSN
CLTN	0.69		0.85	0.89	0.15	0.52	0.82	-0.76	-0.65	CLTN
NWRN	0.58	0.85		0.85	0.25	0.24	0.72	-0.58	-0.59	NWRN
SANN	0.59	0.89	0.85		0.15	0.38	0.79	-0.71	-0.67	SANN
MOLN	-0.09	0.15	0.25	0.15		-0.17	0.21	-0.34	-0.25	MOLN
ASCN	0.77	0.52	0.24	0.38	-0.17		0.31	-0.46	-0.24	ASCN
SHLTN	0.46	0.82	0.72	0.79	0.21	0.31		-0.72	-0.67	SHLTN
ADXN	-0.53	-0.76	-0.58	-0.71	-0.34	-0.46	-0.72		0.74	ADXN
EVE	-0.38	-0.65	-0.59	-0.67	-0.25	-0.24	-0.67	0.74		EVE
	VBSN	CLTN	NWRN	SANN	MOLN	ASCN	SHLTN	ADXN	EVE

High positive correlations

SANN	+ 0.89	CLTN
NWRN	+ 0.85	CLTN
SANN	+ 0.85	NWRN
SHLTN	+ 0.82	CLTN
SHLTN	+ 0.79	SANN
ASCN	+ 0.77	VBSN

High negative correlations

ADXN	- 0.76	CLTN
ADXN	- 0.72	SHLTN
ADXN	- 0.71	SANN
EVE	- 0.67	SHLTN
EVE	- 0.67	SANN
EVE	- 0.65	CLTN

Risk-Adjusted Indicators

There is a big difference between DocMorris Stock performing well and DocMorris Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze DocMorris' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
VBSN	0.90	0.11	0.04	(0.32)	0.90	(1.40)	2.58	(1.72)	6.35
CLTN	1.60	0.24	0.10	5.49	1.82	(1.85)	3.78	(2.45)	11.91
NWRN	3.05	0.63	0.18	2.56	2.81	(3.77)	6.92	(5.30)	21.18
SANN	2.28	0.29	0.11	1.00	2.17	(2.99)	5.79	(4.47)	18.95
MOLN	3.04	0.33	0.08	0.81	3.31	(3.60)	7.56	(5.28)	22.81
ASCN	2.08	0.60	0.32	(1.99)	1.31	(2.88)	6.44	(2.58)	19.28
SHLTN	6.62	1.52	0.18	4.46	6.47	(9.63)	18.97	(9.35)	92.47
ADXN	2.54	(0.29)	0.00	0.28	0.00	0.00	5.28	(6.90)	17.23
EVE	3.19	(0.16)	0.00	0.17	0.00	0.00	7.89	(7.45)	23.36

DocMorris Competitive Analysis

The better you understand DocMorris competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, DocMorris' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across DocMorris' competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	DOCM	VBSN	CLTN	NWRN	SANN	MOLN	ASCN	SHLTN	ADXN	EVE
	0.35 5.68 DocMorris	1.33 148.00 IVF	0.74 54.00 Coltene	0.75 20.15 Newron	0.32 12.60 Santhera	3.66 3.42 Molecular	0.57 5.26 Ascom	3.77 1.10 SHLTN	0.40 0.05 Addex	10.47 0.77 Evolva
Market Volatility (90 Days Market Risk)	Relatively risky	Very steady	Very steady	Not too volatile	Somewhat reliable	Unstable	Moderately volatile	Out of control	Out of control	Abnormally volatile
Market Performance (90 Days Performance)	Mild	Fair	Good	Good	Fair	Weakest	Solid	Fair	Weakest	Weakest
Odds of Financial Distress (Probability Of Bankruptcy)	Moderate	Tiny	Tiny	Low	Strong	Low	Tiny	High	Low	Risky
Current Valuation (Equity Enterprise Value)	Over Valued	Over Valued	Under Valued	Under Valued	Fairly Valued	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Strong Sell	Strong Sell	Buy	Cautious Hold	Cautious Hold	Strong Sell	Hold	Strong Sell	Strong Sell	Strong Sell
Current Ratio	N/A	4.56	1.35	13.9	2.19	14.37	1.73	1.43	18.06	4.57
Net Asset	778.13 M	189.01 M	186.95 M	63.91 M	152.49 M	158.53 M	189.9 M	80.76 M	10.67 M	7.54 M
Profit Margin	-0.11	0.12	0.0595	0.42	-1.34	N/A	0.0105	-0.5	N/A	N/A
EBITDA	(37.02 M)	29.57 M	34.23 M	25.94 M	(15.89 M)	(51.63 M)	13.8 M	(18.15 M)	(4.65 M)	3.7 M
Operating Margin	-0.0981	0.12	0.0638	0.11	-1.48	N/A	0.0357	-0.13	-14.04	N/A
Current Valuation	357.28 M	254.46 M	352.17 M	407.81 M	193.91 M	17.62 M	176.38 M	40.1 M	5.23 M	74.77 K
Price To Book	0.57	2.39	3.01	277.33	6.56	1.26	1.85	1.39	1.24	0.99
Retained Earnings	(596.93 M)	139.96 M	256.95 M	10.69 M	(614.69 M)	(246.29 M)	69.5 M	(108.22 M)	(353.36 M)	(475.21 M)
Five Year Return	N/A	1.36	2.9	N/A	N/A	N/A	2.97	N/A	N/A	N/A
Beta	1.83	0.3	0.8	0.7	-0.74	0.57	1.27	-0.14	1.94	-0.19
Number Of Employees	1.45 K	309	1.18 K	22	78	158	1.37 K	526	2	N/A
Shares Outstanding	48.6 M	2.4 M	5.98 M	19.96 M	13.39 M	37.4 M	35.92 M	37.06 M	147.84 M	7.21 M
Cash Flow From Operations	(26.6 M)	20.4 M	28.56 M	(17.61 M)	(35.53 M)	(59.25 M)	20 M	(372 K)	(5.37 M)	(2.44 M)
Annual Yield	N/A	0.0213	0.046	N/A	N/A	N/A	0.0191	N/A	N/A	N/A
Total Debt	312.21 M	1.3 M	40 M	50.47 M	41.17 M	2.44 M	115.5 M	16.12 M	41.99 K	945.3 K
Return On Equity	-0.27	0.13	0.15	-8.4	-2.88	-0.51	0.0412	-0.52	-0.73	-0.13
Return On Asset	-0.077	0.0775	0.0729	0.51	-0.27	-0.27	0.0275	-0.0573	-0.16	-0.0739
Book Value Per Share	10.33	60.49	15.13	0.0726	-0.2	2.55	1.97	1.81	0.051	0.87
Total Asset	778.13 M	189.01 M	186.95 M	63.91 M	152.49 M	158.53 M	189.9 M	80.76 M	10.67 M	7.54 M
Target Price	8.37	N/A	56.67	40.3	30.0	9.0	7.03	10.5	0.16	70.0
Last Dividend Paid	N/A	3.2	2.5	N/A	N/A	N/A	0.1	N/A	N/A	N/A
Debt To Equity	N/A	N/A	84.2	0.7	196.0	0.02	24.0	2.4	N/A	1.6
Shares Owned By Institutions	22.3	1.45	19.34	11.78	4.74	43.98	51.46	26.75	1.14	2.58
Market Capitalization	275.8 M	360 M	325.66 M	402.21 M	142.15 M	136.88 M	189.29 M	40.76 M	7.33 M	6.16 M
Price To Earning	N/A	25.67	25.3	-11.88	-7.01	2.02	21.86	6.77	39.53	-4.33
Price To Sales	0.26	2.25	1.35	6.72	3.44	166.37	0.67	0.72	46.25	0.34
Net Income	(97.25 M)	20.3 M	20.47 M	21.39 M	(41.97 M)	(54.04 M)	3.7 M	(27.75 M)	(4.91 M)	1.04 M
Earnings Per Share	-4.56	7.92	2.4	1.25	-5.38	-1.62	0.08	-0.74	-0.06	-0.12
Shares Owned By Insiders	17.33	76.37	56.8	13.84	15.14	8.3	1.21	50.38	6.06	41.57
Revenue	1.02 B	158.79 M	250.16 M	51.39 M	39.12 M	4.97 M	286.7 M	56.78 M	410.04 K	N/A
Working Capital	97.09 M	117.66 M	53.37 M	37.6 M	29.67 M	143.5 M	50.3 M	931 K	2.74 M	6.6 M
Cash And Equivalents	95.37 M	94.93 M	21.86 M	58.99 M	22.59 M	267.13 M	18.6 M	576 K	20.48 M	11 M
Cash Per Share	N/A	14.98	3.43	3.31	2.07	8.22	0.59	0.84	1.58	0.08
Gross Profit	230.27 M	89.07 M	159.13 M	59.88 M	6.57 M	(40.4 M)	133.3 M	25.72 M	(525.65 K)	5.13 M
Day Typical Price	5.74	148.67	54.07	20.33	12.56	3.5	5.24	1.1	0.0508	0.8
Accumulation Distribution	7180.92	0.99	126.82	7577.79	832.98	2568.39	2369.53	637.77	31484.13	115.48
Market Facilitation Index	0.0	0.027	5.0E-4	0.0	0.0	0.0	0.0	0.0	N/A	1.0E-4
Daily Balance Of Power	(0.11)	(1.00)	(0.22)	0.1429	(0.11)	(0.52)	0.2308	0.8	0.0588	(1.12)
Period Momentum Indicator	(0.02)	(2.00)	(0.40)	0.15	(0.04)	(0.13)	0.03	0.04	2.0E-4	(0.09)
Rate Of Daily Change	1.0	0.99	0.99	1.01	1.0	0.96	1.01	1.04	1.0	0.9
Day Median Price	5.77	149.0	54.1	20.42	12.54	3.55	5.24	1.1	0.0513	0.81
Price Action Indicator	(0.10)	(2.00)	(0.30)	(0.20)	0.04	(0.19)	0.04	0.025	(0)	(0.09)
Relative Strength Index	49.28	58.85	53.51	47.38	52.09	53.32	70.66	54.06	41.79	45.45
Coefficient Of Variation	2911.95	1151.51	825.68	611.71	1063.15	1150.29	541.67	759.08	(1,052)	(2,293)
Mean Deviation	2.69	0.9035	1.6	3.05	2.28	3.04	2.08	6.62	2.54	3.19
Jensen Alpha	0.073	0.1112	0.2434	0.6285	0.2927	0.3307	0.6029	1.52	(0.29)	(0.16)
Total Risk Alpha	(0.10)	0.0252	0.1218	0.4066	0.1092	0.1072	0.3997	0.8479	(0.55)	(0.48)
Sortino Ratio	0.0221	0.0415	0.0993	0.1839	0.1095	0.0841	0.3203	0.1827	N/A	N/A
Downside Variance	12.24	1.77	4.15	10.51	5.77	13.24	2.92	66.65	N/A	N/A
Standard Deviation	3.79	1.25	2.11	3.97	3.36	4.13	3.25	11.73	3.54	4.56
Kurtosis	1.65	0.5753	1.64	0.6172	4.47	2.09	10.12	15.75	0.65	0.5495
Potential Upside	7.96	2.58	3.78	6.92	5.79	7.56	6.44	18.97	5.28	7.89
Treynor Ratio	0.1094	(0.32)	5.49	2.56	0.9951	0.8103	(1.99)	4.46	0.2793	0.1689
Maximum Drawdown	21.23	6.35	11.91	21.18	18.95	22.81	19.28	92.47	17.23	23.36
Variance	14.39	1.55	4.44	15.77	11.28	17.08	10.57	137.5	12.51	20.83
Market Risk Adjusted Performance	0.1194	(0.31)	5.5	2.57	1.01	0.8203	(1.98)	4.47	0.2893	0.1789
Risk Adjusted Performance	0.0333	0.0679	0.0954	0.1282	0.0769	0.072	0.1433	0.1061	(0.06)	(0.02)
Skewness	0.3239	0.2589	(0.39)	0.5437	1.58	0.6567	2.64	2.97	0.0552	0.1053
Semi Deviation	3.33	0.9023	1.82	2.81	2.17	3.31	1.31	6.47	N/A	N/A
Information Ratio	0.0204	0.0443	0.096	0.1501	0.0783	0.0741	0.1683	0.1272	(0.11)	(0.06)
Value At Risk	(5.59)	(1.72)	(2.45)	(5.30)	(4.47)	(5.28)	(2.58)	(9.35)	(6.90)	(7.45)
Expected Short fall	(3.19)	(1.40)	(1.85)	(3.77)	(2.99)	(3.60)	(2.88)	(9.63)	N/A	N/A
Downside Deviation	3.5	1.33	2.04	3.24	2.4	3.64	1.71	8.16	N/A	N/A
Semi Variance	11.09	0.8142	3.3	7.88	4.7	10.99	1.71	41.84	N/A	N/A

DocMorris Competition Performance Charts

Five steps to successful analysis of DocMorris Competition

DocMorris' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by DocMorris AG in relation to its competition. DocMorris' competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of DocMorris in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact DocMorris' competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to DocMorris AG, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your DocMorris position

In addition to having DocMorris in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Russia On Wall Street Thematic Idea Now

Russia On Wall Street

Cross-sector and cross-instrument bundle of publicly traded Russian entities that are expected to be listed on USA exchanges or over the counter. The Russia On Wall Street theme has 23 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Russia On Wall Street Theme or any other thematic opportunities.

View All Next

Launch

Additional Tools for DocMorris Stock Analysis

When running DocMorris' price analysis, check to measure DocMorris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DocMorris is operating at the current time. Most of DocMorris' value examination focuses on studying past and present price action to predict the probability of DocMorris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DocMorris' price. Additionally, you may evaluate how the addition of DocMorris to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

DocMorris Competitors

DocMorris vs Evolva Holding Correlation

Very good diversification

Moving together with DocMorris Stock

Specify up to 10 symbols:

DocMorris Competition Correlation Matrix

High positive correlations

High negative correlations

Risk-Adjusted Indicators

DocMorris Competitive Analysis

DocMorris Competition Performance Charts

Five steps to successful analysis of DocMorris Competition

Complement your DocMorris position

Did You Try This Idea?

Run Russia On Wall Street Thematic Idea Now

Russia On Wall Street

Additional Tools for DocMorris Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY